Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Jefferies Financial Group Inc.

Start price
Target price
Perf. (%)
€28.72
07.04.23
€36.66
07.04.24
41.26%
08.04.24

buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€40.98
28.11.23
€48.00
28.11.25
-19.28%
25.03.24

Could be worthwhile Investment >10% per year
Undervalued
buy
Lithium Chile Inc.

Start price
Target price
Perf. (%)
€0.68
12.06.23
-
03.07.26
-46.02%
24.11.23

buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€39.30
13.10.22
-
13.10.23
-0.71%
14.10.23

buy
Cfc Industriebeteiligungen

Start price
Target price
Perf. (%)
€0.94
15.01.23
€1.85
24.08.23
51.06%
24.08.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€48.16
23.08.22
€65.00
23.08.23
1.00%
24.08.23

buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€43.62
28.07.23
€60.00
29.07.24
-2.57%
05.08.23

Could be worthwhile Investment >10% per year
Undervalued
buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€42.52
18.04.23
€50.00
18.04.24
6.54%
24.06.23

Could be worthwhile Investment >10% per year
Undervalued
buy
Lithium Chile Inc.

Start price
Target price
Perf. (%)
€0.61
09.06.23
-
09.07.23
11.51%
12.06.23

buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€43.34
03.05.23
-
03.05.24
3.05%
13.05.23

Ranpak Holdings Corp

Start price
Target price
Perf. (%)
€4.56
18.09.22
-
18.09.23
-13.60%
24.04.23

Probably not worthwhile Investment
buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€42.28
14.04.23
€50.00
14.05.23
-1.04%
15.04.23

Could be worthwhile Investment >10% per year
Undervalued
buy
Hemogenyx Pharmaceuticals

Start price
Target price
Perf. (%)
€0.020
03.02.23
-
03.03.23
-2.56%
04.03.23

Could be worthwhile Investment >10% per year
buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€37.52
29.12.22
€50.00
29.12.23
-1.39%
07.01.23

Could be worthwhile Investment >10% per year
Undervalued
buy
Heliad Equity Partners KGaA

Start price
Target price
Perf. (%)
€10.55
13.12.21
-
13.12.22
-61.42%
14.12.22

buy
Lithium Chile Inc.

Start price
Target price
Perf. (%)
€0.51
29.07.22
-
25.08.25
-1.77%
10.11.22

buy
Scherzer U. Co. AG

Start price
Target price
Perf. (%)
€3.18
09.11.21
-
09.11.22
-17.61%
10.11.22

buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€84.50
14.09.21
-
14.09.22
-50.67%
15.09.22

buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€55.50
02.08.22
€101.00
02.08.23
-0.36%
09.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Lithium Chile Inc.

Start price
Target price
Perf. (%)
€0.49
28.06.22
-
19.07.23
4.41%
29.07.22

buy
Emerita Resources

Start price
Target price
Perf. (%)
€1.22
27.07.21
€3.00
27.07.22
-46.48%
28.07.22

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Little known brand
Risky balance sheet
buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€69.00
10.07.21
-
10.07.22
-25.94%
11.07.22

Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
Growths faster than the competition
buy
Media And Games Invest SE

Start price
Target price
Perf. (%)
€5.78
08.07.21
-
08.07.22
-61.90%
08.07.22

buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€69.90
08.07.21
-
08.07.22
-27.04%
08.07.22

buy
Hemogenyx Pharmaceuticals

Start price
Target price
Perf. (%)
€0.017
06.06.21
€0.050
06.06.22
-35.29%
07.06.22

Could be worthwhile Investment >10% per year